🦠 Update on “5 BY 25”: Progress, Challenges and Next Steps in Countering AMR
GARDP will host a live webinar reflecting ...
🦠 Update on “5 BY 25”: Progress, Challenges and Next Steps in Countering AMR
GARDP will host a live webinar reflecting on the “5 BY 25” initiative, launched in 2019 with the ambitious goal of developing five new antibiotic treatments between 2020 and 2025. The session will highlight key achievements, lessons learned, and remaining challenges, while outlining how GARDP is building on this progress to advance sustainable, public health–driven antibiotic R&D and access 🌍💊.
The webinar will feature insights from leading experts Anand Anandkumar (Bugworks), Manica Balasegaram (GARDP), Glenda Gray (SAMRC), and David Paterson (ADVANCE-ID), and will be moderated by Herman Goossens (University of Antwerp).
📅 15 January 2026 | 12:00–13:00 CET 💬 Live broadcast with interactive Q&A
🦠 Update on “5 BY 25”: Progress, Challenges and Next Steps in Countering AMR
GARDP will host a live webinar reflecting on the “5 BY 25” initiative, launched in 2019 with the ambitious goal of developing five new antibiotic treatments between 2020 and 2025. The session will highlight key achievem...
🦠 Update on “5 BY 25”: Progress, Challenges and Next Steps in Countering AMR
GARDP will host a live webinar reflecting on the “5 BY 25” initiative, launched in 2019 with the ambitious goal of developing five new antibiotic treatments between 2020 and 2025. The session will highlight key achievements, lessons learned, and remaining challenges, while outlining how GARDP is building on this progress to advance sustainable, public health–driven antibiotic R&D and access 🌍💊.
The webinar will feature insights from leading experts Anand Anandkumar (Bugworks), Manica Balasegaram (GARDP), Glenda Gray (SAMRC), and David Paterson (ADVANCE-ID), and will be moderated by Herman Goossens (University of Antwerp).
📅 15 January 2026 | 12:00–13:00 CET 💬 Live broadcast with interactive Q&A
Wir nutzen Cookies auf unserer Website. Einige von ihnen sind essenziell für den Betrieb der Seite, während andere uns helfen, diese Website und die Nutzererfahrung zu verbessern (Tracking Cookies). Sie können selbst entscheiden, ob Sie die Cookies zulassen möchten. Bitte beachten Sie, dass bei einer Ablehnung womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen.
DE 
EN 
